JDRF International logo

JDRF International

JDRF is now Breakthrough T1D

931 employees · est. 1970 · New York, United States

VS
SAB BIO logo

SAB BIO

Working to transform treatment for people living with type 1 diabetes through a unique disease-modifying therapy

88 employees · est. 2014 · Miami, United States

JDRF International is the older company (1970 vs 2014); JDRF International is the larger of the two.

Side-by-Side Comparison

JDRF International SAB BIO
Founded
1970 older 2014
Headquarters
New York, United States Miami, United States
Employees
931 larger 88
Industry
Health Care Biotechnology, Health and Wellness
Funding Stage
Grant Post Ipo Equity
Total Funding
$3.00M $186.32M
Funding Rounds
1 7
Services
Not tracked yet Not tracked yet
Target Customers
Not tracked yet Not tracked yet
Taxonomy
Type 1 Diabetes, Research Organization, Advocacy, Government Advocacy, Medical Research, Patient Education, Patient Empowerment, Health Advocacy, Cure Research, Chronic Illness Advocacy, Healthcare Organization Biopharmaceuticals, Immunotherapy, Type 1 Diabetes, Clinical-stage, Disease-modifying, Antibody Therapeutics, Immunoglobulins, Antibody Science, Immunology, Autoimmune Diseases, Public Health, Rare Conditions, Long-term Diseases, Pandemic Threats
Website
jdrf.org sab.bio
JDRF International logo

About JDRF International

JDRF International is a leading global organization dedicated to type 1 diabetes research and advocacy. With a focus on improving the lives of individuals with type 1 diabetes and working towards finding a cure, JDRF invests in promising research, advocates for progress by collaborating with governm...

SAB BIO logo

About SAB BIO

SAb Biotherapeutics is a biotechnology startup founded in 2014 and headquartered in the United States. The company is dedicated to developing a disease-modifying immunotherapy aimed at delaying the onset and progression of type 1 diabetes. They have a novel immunotherapy platform focused on developi...

We will tell you when either one moves

BounceWatch watches JDRF International and SAB BIO for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at JDRF International and SAB BIO — by email.

Frequently Asked Questions

JDRF International — JDRF is now Breakthrough T1D. SAB BIO — Working to transform treatment for people living with type 1 diabetes through a unique disease-modifying therapy. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
JDRF International has raised $3.00M while SAB BIO has raised $186.32M.
JDRF International and SAB BIO operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare JDRF International with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at JDRF International on 14 Sep 2024, and SAB BIO on 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes